Paola Zanovello
Affiliations: | Institute of Oncology | University of Padua (Italy) |
Google:
"Paola Zanovello"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bongiovanni D, Tosello V, Saccomani V, et al. (2020) Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia. Oncogene. 39: 6544-6555 |
Tosello V, Bongiovanni D, Liu J, et al. (2020) Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination. Leukemia |
Saccomani V, Grassi A, Piovan E, et al. (2020) miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia. Cells. 9 |
Scaini MC, Pigozzo J, Pizzi M, et al. (2019) Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells. Melanoma Research. 29: 89-94 |
Piovan E, Tosello V, Amadori A, et al. (2018) Chemotactic Cues for NOTCH1-Dependent Leukemia. Frontiers in Immunology. 9: 633 |
Bordin F, Piovan E, Masiero E, et al. (2018) loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia. Haematologica. 103: 266-277 |
Tosi A, Dalla Santa S, Cappuzzello E, et al. (2017) Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1. Oncoimmunology. 6: e1313371 |
Cappuzzello E, Sommaggio R, Zanovello P, et al. (2017) Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells. Cytokine & Growth Factor Reviews. 36: 99-105 |
Turrini R, Merlo A, Martorelli D, et al. (2017) A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors. Oncoimmunology. 6: e1304338 |
Marigo I, Zilio S, Desantis G, et al. (2016) T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells. Cancer Cell. 30: 651 |